Frederic S. Resnic

A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial)

Simon Dixon, José P.S. Henriques, Laura Mauri et al. · JACC: Cardiovascular Interventions · 2009 · 329 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Patient Safety +8

No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention

Frederic S. Resnic, Marco Vugman Wainstein, Michael K.Y. Lee et al. · American Heart Journal · 2003 · 249 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +8

Association of Public Reporting for Percutaneous Coronary Intervention With Utilization and Outcomes Among Medicare Beneficiaries With Acute Myocardial Infarction

Karen E. Joynt, Daniel M. Blumenthal, E. John Orav et al. · JAMA · 2012 · 192 citations

A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices

Nipun Arora, Michael E. Matheny, Carrie Sepke et al. · American Heart Journal · 2007 · 190 citations

Propensity Analysis, Cardiovascular Disease, Peripheral Intervention +10

Bleeding Avoidance Strategies

Harold L. Dauerman, Sunil V. Rao, Frederic S. Resnic et al. · Journal of the American College of Cardiology · 2011 · 157 citations

Thrombosis, Avoidance Strategies, Patient Safety +6